Cargando…
OnabotulinumtoxinA for Hemicrania Continua: open label experience in 9 patients
BACKGROUND: Hemicrania continua is a strictly unilateral, continuous headache, typically mild to moderate in severity, with severe exacerbations commonly accompanied by cranial autonomic features and migrainous symptoms. It is exquisitely responsive to Indomethacin. However, some patients cannot tol...
Autores principales: | Miller, Sarah, Correia, Fernando, Lagrata, Susie, Matharu, Manjit S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385246/ https://www.ncbi.nlm.nih.gov/pubmed/25902798 http://dx.doi.org/10.1186/s10194-015-0502-z |
Ejemplares similares
-
EHMTI-0278. Onabotulinum toxin a for hemicrania continua: a case series of 8 patients
por: Miller, S, et al.
Publicado: (2014) -
Non-invasive vagus nerve stimulation is beneficial in chronic paroxysmal hemicrania
por: Kamourieh, Salwa, et al.
Publicado: (2019) -
Hemicrania continua
por: Rapoport, Alan M., et al.
Publicado: (2004) -
Hemicrania Continua
por: Prakash, Sanjay, et al.
Publicado: (2018) -
EHMTI-0326. OnabotulinumtoxinA for the treatment of chronic paroxysmal hemicrania: a case report
por: Dolezil, D
Publicado: (2014)